Bimatoprost - SpyGlass Pharma
Latest Information Update: 05 Apr 2024
At a glance
- Originator SpyGlass Pharma
- Class Amides; Antiglaucomas; Lipids; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin F2alpha receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Glaucoma; Ocular hypertension